²úÆ·¹©Ó¦ÑÎËáÒÁÁ¢Ì濵

  • ·¢²¼ÈÕÆÚ£º2024-05-07
  • ÓÐЧÆÚÏÞ£º30Ìì
ºþ±±ºãÂÌÔ´¿Æ¼¼ÓÐÏÞ¹«Ë¾ VIP
C33H39ClN4O6
623.139

ÏêϸÐÅÏ¢
  • ;ÑÎËáÒÁÁ¢Ì濵;ÑÎËáÒÀÁ¢Ì濵;ÒÁÁ¢Ì濵ÑÎËáÑÎ
  • Irinotecan HCL
  • ;Irinotecan, Hydrochloride;Irinotecan Hydrochloride;(S)-[1,4'-Bipiperidine]-1'-Carboxylic Acid, 4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1h-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester Hydrochloride;(S)-4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1h-Pyrano[3',4':6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester;Topotecin Hydrochloride; ;(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride trihydrate;(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate;(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate hydrochloride (1:1);
  • InChI=1/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
  • 250-256¡æ (dec.)
  • 873.4°C at 760 mmHg
  • 482°C

ÃâÔðÉùÃ÷£ºÒÔÉÏËùչʾµÄÐÅÏ¢ÓÉÆóÒµ×ÔÐÐÌṩ£¬ÄÚÈݵÄÕæʵÐÔ¡¢×¼È·ÐԺͺϷ¨ÐÔÓÉ·¢²¼ÆóÒµ¸ºÔ𣬻¯¹¤Íø¶Ô´Ë²»³Ðµ£Èκα£Ö¤ÔðÈΡ£ÎÒÃÇÔ­ÔòÉϽ¨ÒéÄúÑ¡Ôñ»¯¹¤Íø¸ß¼¶»áÔ±»òVIP»áÔ±¡£